ATMA’s Calgary Journey Clinic will house Canada’s first palliative care program based on psychedelic-assisted therapy as it expands the use of legal psychedelic therapy in Alberta CALGARY, AB, Feb. 16, 2021 /CNW/ – ATMA Journey Centers Inc. (“ATMA“), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today the official opening of the…


Previous articleEntheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development
Next articleTryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders